Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,198 Cr
down ₹142 Cr vs Dec 2024
- Stocks held
- 31
- up 1 vs Dec 2024
- Top 10 weight
- 63.2%
- of the portfolio in its ten largest
- Cash & debt
- 0.8%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 19
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In January 2025 it disclosed 31 stocks worth ₹3,198 Cr, down ₹142 Cr from Dec 2024. Its largest positions were Sun Pharmaceutical Industries Limited (10.2%), Cipla Limited (8.3%), Suven Pharmaceuticals Limited (8.2%); the ten largest together made up 63.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 63.7% of its equity. Cash and debt stood at 0.8%. Compared with Dec 2024 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
11%
Holds more cash than 11% of peers
Holdings in January 2025
Download CSVEvery line the fund disclosed, with the change against Dec 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 10.23%
- Δ weight
- down 0.36 pts
- Value
- ₹327 Cr
- Δ value
- down ₹26.7 Cr
- Status
- Trimmed
- Weight
- 8.28%
- Δ weight
- up 0.09 pts
- Value
- ₹265 Cr
- Δ value
- down ₹8.9 Cr
- Status
- Trimmed
- Weight
- 8.21%
- Δ weight
- down 0.28 pts
- Value
- ₹263 Cr
- Δ value
- down ₹20.9 Cr
- Status
- Trimmed
- Weight
- 7.24%
- Δ weight
- down 0.90 pts
- Value
- ₹232 Cr
- Δ value
- down ₹40.4 Cr
- Status
- Trimmed
- Weight
- 6.75%
- Δ weight
- up 1.05 pts
- Value
- ₹216 Cr
- Δ value
- up ₹25.6 Cr
- Status
- Added
- Weight
- 5.77%
- Δ weight
- up 0.99 pts
- Value
- ₹184 Cr
- Δ value
- up ₹25 Cr
- Status
- Added
- Weight
- 4.39%
- Δ weight
- up 0.01 pts
- Value
- ₹140 Cr
- Δ value
- down ₹6 Cr
- Status
- Trimmed
- Weight
- 4.15%
- Δ weight
- up 0.08 pts
- Value
- ₹133 Cr
- Δ value
- down ₹3.2 Cr
- Status
- Trimmed
- Weight
- 4.12%
- Δ weight
- up 0.62 pts
- Value
- ₹132 Cr
- Δ value
- up ₹14.7 Cr
- Status
- Added
- Weight
- 4.10%
- Δ weight
- down 0.45 pts
- Value
- ₹131 Cr
- Δ value
- down ₹20.8 Cr
- Status
- Trimmed
- Weight
- 3.94%
- Δ weight
- up 0.07 pts
- Value
- ₹126 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 3.30%
- Δ weight
- up 0.07 pts
- Value
- ₹105 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 3.28%
- Δ weight
- down 0.27 pts
- Value
- ₹105 Cr
- Δ value
- down ₹13.7 Cr
- Status
- Trimmed
- Weight
- 2.91%
- Δ weight
- up 0.40 pts
- Value
- ₹93 Cr
- Δ value
- up ₹9.1 Cr
- Status
- Added
- Weight
- 2.83%
- Δ weight
- down 0.12 pts
- Value
- ₹90.5 Cr
- Δ value
- down ₹8 Cr
- Status
- Trimmed
- Weight
- 2.82%
- Δ weight
- up 0.01 pts
- Value
- ₹90.2 Cr
- Δ value
- down ₹3.7 Cr
- Status
- Trimmed
- Weight
- 2.67%
- Δ weight
- up 0.18 pts
- Value
- ₹85.4 Cr
- Δ value
- up ₹2.3 Cr
- Status
- Added
- Weight
- 2.53%
- Δ weight
- down 0.64 pts
- Value
- ₹80.8 Cr
- Δ value
- down ₹25 Cr
- Status
- Trimmed
- Weight
- 1.63%
- Δ weight
- down 0.01 pts
- Value
- ₹52 Cr
- Δ value
- down ₹2.7 Cr
- Status
- Trimmed
- Weight
- 1.40%
- Δ weight
- up 0.11 pts
- Value
- ₹44.9 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Weight
- 1.39%
- Δ weight
- up 0.17 pts
- Value
- ₹44.6 Cr
- Δ value
- up ₹3.7 Cr
- Status
- Added
- Weight
- 1.32%
- Δ weight
- down 0.17 pts
- Value
- ₹42.1 Cr
- Δ value
- down ₹7.5 Cr
- Status
- Trimmed
- Weight
- 1.10%
- Δ weight
- up 0.18 pts
- Value
- ₹35 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 1.06%
- Δ weight
- down 0.05 pts
- Value
- ₹34 Cr
- Δ value
- down ₹3.2 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.79%
- Δ weight
- down 1.73 pts
- Value
- ₹25.4 Cr
- Δ value
- down ₹58.8 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.68%
- Δ weight
- up 0.07 pts
- Value
- ₹21.6 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 0.59%
- Δ weight
- down 0.04 pts
- Value
- ₹18.9 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 0.57%
- Δ weight
- up 0.51 pts
- Value
- ₹18.3 Cr
- Δ value
- up ₹16.1 Cr
- Status
- Added
- Weight
- 0.52%
- Δ weight
- down 0.04 pts
- Value
- ₹16.7 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 0.49%
- Δ weight
- up 0.04 pts
- Value
- ₹15.7 Cr
- Δ value
- up ₹64 L
- Status
- Added
- Weight
- 0.43%
- Δ weight
- down 0.04 pts
- Value
- ₹13.9 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 0.43%
- Δ weight
- up 0.43 pts
- Value
- ₹13.9 Cr
- Δ value
- up ₹13.9 Cr
- Status
- New
- Weight
- 0.07%
- Δ weight
- up 0.03 pts
- Value
- ₹2.3 Cr
- Δ value
- up ₹96 L
- Status
- Added
What changed, Dec 2024 to Jan 2025
New New positions (1)
- Laxmi Dental Limited0.4% · ₹13.9 Cr
Exited Exited (0)
None.
Added Biggest additions
- Globus Medical Incup ₹25.6 Cr (+1.05% pts)
- Illumina Incup ₹25 Cr (+0.99% pts)
- Thyrocare Technologies Limitedup ₹16.1 Cr (+0.51% pts)
- Laurus Labs Limitedup ₹14.7 Cr (+0.62% pts)
- Intuitive Surgical Inc
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2024, the weight rose most in Healthcare Equipment & Supplies (+1.8 pts) and Healthcare Services (+1.5 pts), and fell most in Pharmaceuticals & Biotechnology (−2.7 pts) and Pharmaceuticals (−0.6 pts).
- Healthcare Equipment & Supplies8.5% → 10.2%+1.8 pts
- Healthcare Services17.3% → 18.9%+1.5 pts
- Pharmaceuticals & Biotechnology66.4% → 63.7%−2.7 pts
- Pharmaceuticals5.9% → 5.3%−0.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2022 | Jan 2024 | Jul 2024 | Oct 2024 | Dec 2024 | Jan 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 54.0% | 71.1% | 69.7% | 66.4% | 66.4% | 63.7% |
| Healthcare Services | 29.3% | 13.3% | 14.6% | 18.0% | 17.3% | 18.9% |
| Healthcare Equipment & Supplies | 5.5% | 7.3% | 8.0% | 8.1% | 8.5% | 10.2% |
| Pharmaceuticals | 7.0% | 6.0% | 5.4% | 5.6% | 5.9% | 5.3% |
| Insurance | 2.6% | 1.7% | 1.8% | 1.5% | 1.3% | 1.4% |
| Retailing | 1.6% | 0.6% | 0.5% | 0.4% | 0.5% | 0.4% |
Allocation in Jan 2025change vs Dec 2024
- Pharmaceuticals & Biotechnology (15)63.7%▼ 2.7 pts
- Healthcare Services (8)18.9%▲ 1.5 pts
- Healthcare Equipment & Supplies (3)10.2%▲ 1.8 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jan 2025
0.8%
▼ 1.7 pts vs Dec 2024
- Cash alone
- 0.8%
- cash and net receivables
- A year earlier
- 0.9%
- Jan 2024 · now ▼ 0.1 pts
- Last 12 months
- 0.8% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.